Double Blind Randomized Trial to Compare Gurmar (Gymnema Sylvestre) With Metformin in Type 2 Diabetes

The recruitment status of this study is unknown because the information has not been verified recently.

Verified November 2006 by Postgraduate Institute of Medical Education and Research. Recruitment status was Not yet recruiting

First Received on November 6, 2006. No Changes Posted

Sponsor:	Postgraduate Institute of Medical Education and Research
Collaborators:	Indian Council of Medical Research International Clinical Epidemiology Network (INCLEN) TRUST
Information provided by:	Postgraduate Institute of Medical Education and Research
ClinicalTrials.gov Identifier:	NCT00396851

Purpose

The study plans to compare the glucose-lowering effect of gurmar, a herbal preparation, with metformin in patients with type 2 diabetes

Condition	Intervention
Type 2 Diabetes Mellitus	Drug: Gurmar Drug: Metformin

Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double-Blind Primary Purpose: Treatment

Resource links provided by NLM:

MedlinePlus related topics: Diabetes Diabetes Type 2

Drug Information available for: Gymnema sylvestre Metformin Metformin hydrochloride

U.S. FDA Resources

Further study details as provided by Postgraduate Institute of Medical Education and Research:

Estimated Enrollment:	100
Study Start Date:	January 2007

Eligibility

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00396851

Contacts

Contact: Samir Malhotra, MD, DM

+91-172-27552433

Locations

India
PGIMER	Not yet recruiting
Chandigarh, India, 160012
Contact: Samir Malhotra samirmalhotra345@yahoo.com
Sub-Investigator: Promila Pandhi, MD,DM

Sponsors and Collaborators

Postgraduate Institute of Medical Education and Research

Indian Council of Medical Research

International Clinical Epidemiology Network (INCLEN) TRUST

Investigators

Study Chair:	Deepak Bhasin, MD,DM	PGIMER
Principal Investigator:	Anil Bhansali	PGIMER

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00396851 History of Changes
Other Study ID Numbers:	Pharma 6/700
Study First Received:	November 6, 2006
Last Updated:	November 6, 2006
Health Authority:	India: Ministry of Health

Additional relevant MeSH terms:

Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

Metformin
Hypoglycemic Agents
Physiological Effects of Drugs
Pharmacologic Actions

ClinicalTrials.gov processed this record on February 12, 2012